The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?

Frontiers in Pharmacology
Tomas Di MambroEmanuele Marra

Abstract

Fungal infections have aroused much interest over the last years because of their involvement in several human diseases. Immunocompromission due to transplant-related therapies and malignant cancer treatments are risk factors for invasive fungal infections, but also aggressive surgery, broad-spectrum antibiotics and prosthetic devices are frequently associated with infectious diseases. Current therapy is based on the administration of antifungal drugs, but the occurrence of resistant strains to the most common molecules has become a serious health-care problem. New antifungal agents are urgently needed and it is essential to identify fungal molecular targets that could offer alternatives for development of treatments. The fungal cell wall and plasma membrane are the most important structures that offer putative new targets which can be modulated in order to fight microbial infections. The development of monoclonal antibodies against new targets is a valid therapeutic strategy, both to solve resistance problems and to support the immune response, especially in immunocompromised hosts. In this review, we summarize currently used antifungal agents and propose novel therapeutic approaches, including new fungal molecular targets to ...Continue Reading

References

Apr 1, 1990·Antimicrobial Agents and Chemotherapy·R F HectorD Pappagianis
Jul 1, 1980·Antimicrobial Agents and Chemotherapy·J D DickR Saral
Oct 1, 1994·Trends in Microbiology·H Vanden BosscheF C Odds
Jun 20, 1998·Clinical Microbiology Reviews·T C WhiteR A Bowden
Jan 22, 2002·Medical Mycology·C M Douglas
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrLawrence Corey
Apr 12, 2002·Lancet·Dimitrios P Kontoyiannis, Russell E Lewis
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·G DelmasD S Perlin
Sep 14, 2002·Current Genetics·Cesar Roncero
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Ruth C MatthewsJames Burnie
Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shahid HusainNina Singh
Aug 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ekaterina DadachovaArturo Casadevall
Oct 24, 2003·The Journal of Hospital Infection·R P Hobson
Nov 1, 2003·The Lancet Infectious Diseases·Philippe EggimannDidier Pittet
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·E DadachovaL Pirofski
Aug 27, 2005·The Journal of Antimicrobial Chemotherapy·Malcolm D Richardson
Sep 9, 2005·The Journal of Experimental Medicine·Antonella TorosantucciAntonio Cassone
Feb 24, 2006·Nature·Tobias C WaltherPeter Walter
Apr 20, 2006·Infection and Immunity·María J SevillaJosé Pontón
Jun 15, 2006·Journal of Medical Microbiology·D A EnochN M Brown
Dec 23, 2006·Expert Review of Vaccines·Antonio Cassone, Antonella Torosantucci
Dec 12, 2007·Handbook of Experimental Pharmacology·N Lonberg
Jun 10, 2008·Applied and Environmental Microbiology·Christina GrosseAxel A Brakhage
Dec 3, 2008·Antimicrobial Agents and Chemotherapy·Paul A AeedAke P Elhammer
Dec 10, 2008·The Journal of Cell Biology·Guido GrossmannWidmar Tanner
Jul 3, 2009·Fungal Genetics and Biology : FG & B·Nicolas RispailAntonio Di Pietro
Jul 20, 2010·Yeast·Jan MalinskyWidmar Tanner
Sep 9, 2010·Antimicrobial Agents and Chemotherapy·Thomas D Edlind, Santosh K Katiyar
Apr 27, 2011·Antimicrobial Agents and Chemotherapy·Sonia BrenaJosé Pontón
May 20, 2011·Molecular Biology of the Cell·Agustina Olivera-CoutoPablo S Aguilar
Aug 10, 2011·Antimicrobial Agents and Chemotherapy·Mamiko MiyazakiMakoto Asada
Aug 17, 2011·Antimicrobial Agents and Chemotherapy·Scott S WalkerTodd A Black

❮ Previous
Next ❯

Citations

Jan 31, 2020·PLoS Neglected Tropical Diseases·Rob Hooft van HuijsduijnenKei Katsuno
Jan 1, 2020·Current Protein & Peptide Science·Laura C García-CarneroAlma K Tamez-Castrellón
Feb 23, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Abhishek SinhaElah Pick
Oct 6, 2020·Frontiers in Cellular and Infection Microbiology·Brenda KischkelCarlos P Taborda
Nov 25, 2020·Antimicrobial Agents and Chemotherapy·Caroline Mota FernandesMaurizio Del Poeta
Jan 30, 2021·Critical Reviews in Microbiology·Alison Felipe Alencar ChavesWagner Luiz Batista
Jan 10, 2021·European Journal of Medicinal Chemistry·Pedro BrandãoMarta Pineiro
Jan 10, 2021·International Journal of Molecular Sciences·Marija IvanovMarina Soković
Jul 6, 2020·Current Topics in Medicinal Chemistry·Christophe Tratrat
Jul 1, 2020·Current Opinion in Microbiology·Sarah DellièreVishukumar Aimanianda
Jun 2, 2021·ACS Applied Materials & Interfaces·Sebastian SchaeferCyrille Boyer
Jul 3, 2021·Journal of Fungi·Mousa A AlghuthaymiKamel A Abd-Elsalam
Aug 6, 2021·Journal of Basic Microbiology·Saraswathi NagarajShoba Narayan
Aug 14, 2020·Journal of Natural Products·Modibo S MalefoMamoalosi A Selepe
Oct 2, 2021·Scientific Reports·Tomas Di MambroMauro Magnani
Sep 28, 2021·Antimicrobial Agents and Chemotherapy·Alexandre Bezerra Conde FigueiredoMarcio L Rodrigues

❮ Previous
Next ❯

Methods Mentioned

BETA
transglycosylation
nuclear magnetic resonance

Clinical Trials Mentioned

NCT02733432
NCT02629419
NCT02734862
NCT02679456
NCT02267356
NCT02267382

Software Mentioned

Diatheva

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.